testicular cancer

In a move that will significantly expand the restrictions on per- and poly-fluoroalkyl substances (PFAS) – more commonly known as the “forever chemicals” – the International Agency for Research on Cancer has reclassified perfluorooctanoic acid (PFOA) as “carcinogenic to humans.” It did so even though no valid studies show it increases the risk of causing cancer in people. How will this reclassification increase pressure in Europe and the U.S. for more action? Here's a look.
Many cancers are treated with DNA-damaging drugs. But one, testicular cancer, responds so well to the drug cisplatin that the cure rate for early-stage disease is about 100%. Even if the cancer has spread to nearby lymph nodes, there is a five-year survival of 74%. What makes this combination of a particular drug and cell type so unique?
Testicular cancer has always been a bit of an outlier. A new study reinforces this concept, as it finds that almost half of all cases are caused by inheriting faulty genes. In comparison to other cancer types, this figure is very high.
Screen Shot 2015-04-14 at 2.47.57 PMThe bad news is that people keep consuming products that they have been manipulated into believing will help them. But, not only do these products fail to meet expectations, sometimes the exact opposite is true harm instead of help.